MedTrace Logo

Core Biopsy Endo Sonography Study Evaluation of the Significance of the Pro-core® Needle

NCT02181140 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2019-06-18

Study results available
· View outcomes & findings →

Summary

The study is designed to evaluate the diagnostic accuracy of a new designed endoscopic ultrasonography (EUS) Core biopsy aspiration needle in comparison to a conventional EUS aspiration needle in GI-tumors.

Conditions

  • Pancreatic Neoplasm

Interventions

DEVICE

EUS guided FNA and fine needle punction

punction of a suspect area by a EUS guided fine needle as well as pro core fine needle to evacuate histology and smear biologics

Sponsors & Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Thomas Rösch, Prof. Dr. · University Hospital Eppendorf, Hamburg

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02181140 on ClinicalTrials.gov